ARQT Arcutis Biotherapeutics, Inc. - Common stock
$27,03
Prezzo · Ago 19, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$15–$32
72% of range
Rating Analisti
BUY
14 analysts
Prezzo Obiettivo
$37
+36% upside
P/E (TTM)
-207.9
ROE
-9.8%
Margine di Profitto Netto
-4.3%
ARQT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$27.03
Capitalizzazione di Mercato
$3.33B
P/E (TTM)
-207.9
EPS (TTM)
$-0.13
Ricavi (TTM)
$376M
Rendimento div.
—
ROE
-9.8%
D/E Debito/Patrimonio
0.6
Intervallo 52 sett.
$15 – $32
ARQT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$376M
2020-12-31
→
2025-12-31
EPS
$-0.13
2019-12-31
→
2025-12-31
Flusso di cassa libero
$-6M
2020-12-31
→
2025-12-31
Margini
-4.3%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
ARQT
Mediana dei peer
P/E (TTM)
-207.9
—
P/S (TTM)
8.9
18.3
P/B
17.6
3.3
EV / EBITDA
-278.1
—
Price / FCF (Prezzo / FCF)
-528.2
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
ARQT
Mediana dei peer
Operating Margin (Margine Operativo)
-3.2%
—
Net Profit Margin (Margine di Profitto Netto)
-4.3%
-180.4%
ROA
-4.1%
-36.2%
ROE
-9.8%
-43.7%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
ARQT
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
0.6
—
Current Ratio (Rapporto corrente)
3.2
9.7
Quick Ratio
1.5
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
ARQT
Mediana dei peer
Revenue YoY (Ricavi YoY)
91.3%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
367.3%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
ARQT
Mediana dei peer
ARQT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
14 analisti
- Acquisto forte 4 28,6%
- Compra 8 57,1%
- Mantieni 2 14,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
8 analisti · 2026-08-13
Mediana
$37.00
← Sotto tutti i target
$27.03
Basso
$34.00
Alto
$40.00
Target mediano
$37.00
+36,9%
Target medio
$36.88
+36,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.05%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $0.11 | $0.04 | 0.07% |
| 31 Marzo 2026 | $-0.09 | $-0.08 | -0.01% |
| 31 Dicembre 2025 | $0.13 | $0.12 | 0.01% |
| 30 Settembre 2025 | $0.06 | $-0.10 | 0.16% |
| 30 Giugno 2025 | $-0.13 | $-0.16 | 0.03% |
| 31 Marzo 2025 | $-0.20 | $-0.21 | 0.01% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
Stato Patrimoniale 26
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
Flusso di cassa 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
Redditività 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
Tassi di Crescita 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | -253,422,862 | 127,623,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | -258,684,862 | 132,885,000 | 126,997,000 | 126,037 | -237,873,525 | 124,302,000 | 123,481,000 | 111,048,525 | -115,021,987 | 61,727,278 | 61,430,620 | 61,169,089 | -103,995,388 | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
Stato Patrimoniale 26
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
Flusso di cassa 11
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
Redditività 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
Valutazione (TTM) 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $416M | $352M | · | $291M | $223M | $191M | · | $163M | $124M | $96M | · | $47M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $-5M | $-45M | · | $-75M | $-135M | $-154M | · | $-174M | $-203M | $-231M | · | $-304M | $-326M | $-320M | · | $-296M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | -524.4 | -65.4 | · | -31.4 | -13.0 | -12.3 | · | -5.2 | -3.5 | -2.8 | · | -1.0 | -1.7 | -1.9 | · | -3.4 | |
| P/S | 7.9 | 8.4 | · | 7.8 | 7.5 | 9.8 | · | 6.7 | 8.8 | · | · | 7.0 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| P / FCF | · | 1315.8 | · | · | · | -60.1 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 205.0 | -332.3 | · | 273.1 | -117.4 | -78.2 | · | -29.6 | -24.0 | · | · | -11.4 | · | · | · | -12.2 | |
| EV / FCF | · | 1349.1 | · | · | · | -61.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 8.1 | 8.6 | · | 8.0 | 7.7 | 10.0 | · | 7.1 | 9.7 | · | · | 9.0 | · | · | · | 1764.4 | |
| Earnings Yield | -0.19% | -1.5% | · | -3.2% | -7.7% | -8.1% | · | -19.4% | -28.3% | -35.5% | · | -95.9% | -59.5% | -52.5% | · | -29.4% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $376M | $197M | $60M | $4M | $0 |
| Margine Operativo % | -3.2% | -65.3% | -404.5% | — | — |
| Utile netto | $-16M | $-140M | $-262M | $-311M | $-206M |
| EPS Diluito | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.6 | 0.7 | 2.3 | — | — |
| Rapporto corrente | 3.2 | 4.1 | 7.1 | — | — |
| Quick Ratio | 1.5 | 1.8 | 2.4 | — | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-6M | $-112M | $-247M | — | — |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 292 filer · $2.6B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 47 (+10 vs trimestre precedente) | 33 (-9 vs trimestre precedente) | 90 (-8 vs trimestre precedente) | 96 (+4 vs trimestre precedente) | +5.9M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326.098.140 | 12.437.000 | 12,35% | Azioni |
| Frazier Life Sciences Management, L.P. | $258.909.678 | 9.874.511 | 9,80% | Azioni |
| Rubric Capital Management LP | $216.880.749 | 8.271.577 | 8,21% | Azioni |
| Polar Capital Holdings Plc | $173.234.098 | 6.606.945 | 6,56% | Azioni |
| STATE STREET CORP | $152.674.865 | 5.822.840 | 5,78% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $130.805.182 | 4.988.756 | 4,95% | Azioni |
| JENNISON ASSOCIATES LLC | $86.505.943 | 3.299.235 | 3,28% | Azioni |
| D. E. Shaw & Co., Inc. | $81.220.383 | 3.097.650 | 3,08% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $67.179.379 | 2.561.595 | 2,54% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63.688.511 | 2.429.005 | 2,41% | Azioni |
| ORBIMED ADVISORS LLC | $53.541.240 | 2.042.000 | 2,03% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $50.474.363 | 1.925.031 | 1,91% | Azioni |
| JANUS HENDERSON GROUP PLC | $42.621.972 | 1.809.466 | 1,61% | Azioni |
| OBERWEIS ASSET MANAGEMENT INC/ | $35.998.513 | 1.372.941 | 1,36% | Azioni |
| GILDER GAGNON HOWE & CO LLC | $34.432.392 | 1.313.211 | 1,30% | Azioni |
| Pivotal bioVenture Partners Investment Advisor LLC | $33.175.720 | 1.265.283 | 1,26% | Azioni |
| BANK OF AMERICA CORP /DE/ | $33.121.130 | 1.263.201 | 1,25% | Azioni |
| BAMCO INC /NY/ | $32.856.806 | 1.253.120 | 1,24% | Azioni |
| CITADEL ADVISORS LLC | $29.766.543 | 1.135.261 | 1,13% | Azioni |
| Aberdeen Group plc | $28.635.465 | 1.092.123 | 1,08% | Azioni |
| Jones Hill Capital LP | $28.571.960 | 1.089.701 | 1,08% | Azioni |
| GOLDMAN SACHS GROUP INC | $28.558.011 | 1.089.169 | 1,08% | Azioni |
| Perpetual Ltd | $27.642.802 | 1.054.264 | 1,05% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27.555.489 | 1.050.934 | 1,04% | Azioni |
| Ensign Peak Advisors, Inc | $25.552.281 | 974.534 | 0,97% | Azioni |
| Candriam S.C.A. | $24.880.817 | 949.839 | 0,94% | Azioni |
| Driehaus Capital Management LLC | $23.032.330 | 878.426 | 0,87% | Azioni |
| VANGUARD GROUP INC | $22.159.001 | 763.051 | 0,84% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $21.372.918 | 815.138 | 0,81% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21.284.137 | 811.752 | 0,81% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $17.406.855 | 663.877 | 0,66% | Azioni |
| FISHMAN JAY A LTD/MI | $15.601.031 | 595.005 | 0,59% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $14.789.968 | 564.072 | 0,56% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $14.349.629 | 547.278 | 0,54% | Azioni |
| Squarepoint Ops LLC | $14.099.726 | 537.747 | 0,53% | Azioni |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13.110.000 | 500.000 | 0,50% | Azioni |
| Nearwater Capital Markets, Ltd | $12.761.274 | 486.700 | 0,48% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.218.520 | 466.000 | 0,46% | Azioni |
| Privium Fund Management B.V. | $10.471.403 | 399.367 | 0,40% | Azioni |
| NORGES BANK | $10.286.106 | 392.300 | 0,39% | Azioni |
| Patient Square Capital LP | $9.701.400 | 370.000 | 0,37% | Azioni |
| Point72 Asset Management, L.P. | $9.503.413 | 362.449 | 0,36% | Azioni |
| Qube Research & Technologies Ltd | $9.482.778 | 361.662 | 0,36% | Azioni |
| Longaeva Partners L.P. | $9.040.551 | 344.796 | 0,34% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.741.748 | 333.400 | 0,33% | Opzione Call |
| FMR LLC | $8.001.453 | 305.166 | 0,30% | Azioni |
| PEREGRINE CAPITAL MANAGEMENT LLC | $7.641.740 | 291.447 | 0,29% | Azioni |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $7.467.168 | 284.789 | 0,28% | Azioni |
| FIRST TRUST ADVISORS LP | $7.448.184 | 284.065 | 0,28% | Azioni |
| AMERIPRISE FINANCIAL INC | $7.133.676 | 272.070 | 0,27% | Azioni |
| Walleye Capital LLC | $6.818.065 | 260.033 | 0,26% | Azioni |
| Balyasny Asset Management L.P. | $6.374.580 | 243.119 | 0,24% | Azioni |
| PFM Health Sciences, LP | $6.347.049 | 242.069 | 0,24% | Azioni |
| MYDA Advisors LLC | $6.292.800 | 240.000 | 0,24% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $6.054.329 | 230.905 | 0,23% | Azioni |
| Swiss National Bank | $5.873.280 | 224.000 | 0,22% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.763.549 | 219.815 | 0,22% | Azioni |
| Pictet Asset Management Holding SA | $5.350.188 | 200.275 | 0,20% | Azioni |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $5.235.688 | 199.683 | 0,20% | Azioni |
| Woodline Partners LP | $5.113.765 | 195.033 | 0,19% | Azioni |
| BlackRock, Inc. | $4.724.084 | 180.171 | 0,18% | Azioni |
| Cormorant Asset Management, LP | $4.588.500 | 175.000 | 0,17% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $4.586.166 | 174.911 | 0,17% | Azioni |
| TWO SIGMA ADVISERS, LP | $4.533.144 | 156.100 | 0,17% | Azioni |
| RHUMBLINE ADVISERS | $4.471.596 | 170.542 | 0,17% | Azioni |
| Holocene Advisors, LP | $4.293.053 | 163.732 | 0,16% | Azioni |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4.127.788 | 157.429 | 0,16% | Azioni |
| PDT Partners, LLC | $4.066.067 | 155.075 | 0,15% | Azioni |
| CITIGROUP INC | $3.796.394 | 144.790 | 0,14% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3.616.499 | 137.929 | 0,14% | Azioni |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $3.605.250 | 137.500 | 0,14% | Azioni |
| CASTLEARK MANAGEMENT LLC | $3.603.152 | 137.420 | 0,14% | Azioni |
| Eversept Partners, LP | $3.549.008 | 135.355 | 0,13% | Azioni |
| LAZARD ASSET MANAGEMENT LLC | $3.491.088 | 133.146 | 0,13% | Azioni |
| TUDOR INVESTMENT CORP ET AL | $3.458.785 | 131.914 | 0,13% | Azioni |
| MORGAN STANLEY | $3.424.175 | 130.594 | 0,13% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $3.213.419 | 136.393 | 0,12% | Azioni |
| JANE STREET GROUP, LLC | $3.088.716 | 117.800 | 0,12% | Opzione Call |
| 1492 Capital Management LLC | $3.047.052 | 116.211 | 0,12% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.023.149 | 128.317 | 0,11% | Azioni |
| Tejara Capital Ltd | $2.965.062 | 113.084 | 0,11% | Azioni |
| LPL Financial LLC | $2.914.353 | 111.150 | 0,11% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.776.671 | 103.762 | 0,11% | Azioni |
| STEMPOINT CAPITAL LP | $2.594.338 | 98.945 | 0,10% | Azioni |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.496.000 | 95.197 | 0,09% | Azioni |
| CITADEL ADVISORS LLC | $2.480.412 | 94.600 | 0,09% | Opzione Call |
| Aquatic Capital Management LLC | $2.258.329 | 86.130 | 0,09% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.255.628 | 86.027 | 0,09% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $2.135.488 | 81.445 | 0,08% | Azioni |
| WESBANCO BANK INC | $2.126.442 | 81.100 | 0,08% | Azioni |
| Rafferty Asset Management, LLC | $2.117.973 | 80.777 | 0,08% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $1.981.498 | 75.572 | 0,08% | Azioni |
| JUPITER ASSET MANAGEMENT LTD | $1.980.685 | 75.541 | 0,07% | Azioni |
| Erste Asset Management GmbH | $1.956.156 | 73.100 | 0,07% | Azioni |
| FEDERATED HERMES, INC. | $1.952.315 | 74.459 | 0,07% | Azioni |
| Jain Global LLC | $1.917.757 | 73.141 | 0,07% | Azioni |
| Vontobel Holding Ltd. | $1.789.305 | 68.242 | 0,07% | Azioni |
| MetLife Investment Management, LLC | $1.747.012 | 66.629 | 0,07% | Azioni |
| Focus Partners Wealth | $1.651.363 | 62.981 | 0,06% | Azioni |
| CenterBook Partners LP | $1.597.925 | 60.943 | 0,06% | Azioni |
Insider aziendali 18 insider · 2 dirigenti · 12 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Scott L Burrows | Chief Financial Officer | 27 Dicembre 2021 S | 22.679 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 04 Febbraio 2020 C | 270.279 | 0 | 0 | $0 |
| Howard G. Welgus | Direttore | 15 Luglio 2026 M | 37.109 | 0 | 3 | $-243.567 |
| Christopher Peetz | Direttore | 15 Luglio 2026 A | 4.315 | 0 | 0 | $0 |
| Sue-Jean Lin | Direttore | 15 Giugno 2026 S | 27.567 | 0 | 1 | $-120.583 |
| Neha Krishnamohan | Direttore | 05 Giugno 2026 A | 27.901 | 0 | 0 | $0 |
| Terrie Curran | Direttore | 05 Giugno 2026 A | 23.526 | 0 | 0 | $0 |
| Amit Munshi | Direttore | 05 Giugno 2026 A | 9.799 | 0 | 0 | $0 |
| Halley E Gilbert | Direttore | 05 Giugno 2026 A | 27.901 | 0 | 0 | $0 |
| Keith R Leonard | Direttore | 05 Giugno 2026 A | 27.901 | 0 | 0 | $0 |
| Patrick J. Heron | Direttore | 05 Giugno 2026 A | 32.213 | 0 | 0 | $0 |
| Jonathan Silverstein | Direttore | 02 Ottobre 2020 P | 902.286 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Direttore | 04 Febbraio 2020 C | 49.981 | 0 | 0 | $0 |
| Joseph L Turner | Direttore | 30 Gennaio 2020 A | — | 0 | 0 | $0 |
| Patrick Burnett | — | 12 Agosto 2026 M | 119.289 | 0 | 3 | $-419.797 |
| Todd Franklin Watanabe | — | 03 Agosto 2026 S | 717.203 | 0 | 1 | $-114.275 |
| Masaru Matsuda | — | 03 Agosto 2026 S | 126.171 | 0 | 1 | $-32.128 |
| Ricky Sun | — | 09 Giugno 2021 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 depositi | 20 Agosto 2025 | 7,50% | Modifica | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 depositi | 26 Agosto 2022 | — | Deposito iniziale | — | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 depositi | 08 Agosto 2022 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 45 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,38% | 134.950 SH | 08 Agosto 2026 | Giornaliero |
| BBP · ETFis Series Trust I | 1,28% | 32.610 NS | 30 Aprile 2026 | N-PORT |
| GURU · Global X Funds | 0,95% | 23.918 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,88% | 196.991 NS | 30 Aprile 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,54% | 70.043 NS | 31 Maggio 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,36% | 64.844 SH | 08 Agosto 2026 | Giornaliero |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,32% | 145.888 NS | 30 Aprile 2026 | N-PORT |
| IBB · iShares Trust | 0,23% | 812.141 SH | 08 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,22% | 6.809 SH | 08 Agosto 2026 | Giornaliero |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,20% | 9.018 NS | 31 Maggio 2026 | N-PORT |
| IWO · iShares Trust | 0,19% | 1.035.865 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,18% | 122.691 SH | 08 Agosto 2026 | Giornaliero |
| OASC · Unified Series Trust | 0,17% | 6.744 NS | 31 Maggio 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,17% | 88.401 NS | 30 Aprile 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,16% | 74.441 NS | 31 Maggio 2026 | N-PORT |
| BIB · ProShares Trust | 0,13% | 4.587 NS | 31 Maggio 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 41.766 NS | 30 Aprile 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,11% | 3.711 NS | 30 Aprile 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 2.886.529 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 658.480 SH | 08 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | 0,09% | 33.974 SH | 08 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | 0,08% | 85.491 SH | 08 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,08% | 47.709 NS | 30 Aprile 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,07% | 55.080 SH | 08 Agosto 2026 | Giornaliero |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 13.604 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 5.179 NS | 31 Maggio 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 534.058 NS | 31 Maggio 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5.598 SH | 08 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 51.951 SH | 08 Agosto 2026 | Giornaliero |
| ISCB · iShares Trust | 0,04% | 4.781 SH | 08 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 50.560 NS | 30 Aprile 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,04% | 335.913 SH | 08 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,03% | 4.051 NS | 31 Maggio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.307.970 SH | 08 Agosto 2026 | Giornaliero |
| URTY · ProShares Trust | 0,03% | 4.104 NS | 31 Maggio 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 6.296 SH | 08 Agosto 2026 | Giornaliero |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 4.427 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 103 NS | 31 Maggio 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 33.557 NS | 31 Maggio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.941 SH | 08 Agosto 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 31.312 SH | 08 Agosto 2026 | Giornaliero |
| TILT · FlexShares Trust | 0,00% | 3.054 NS | 30 Aprile 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 64.126 NS | 31 Maggio 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.565.928 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.521 SH | 08 Agosto 2026 | Giornaliero |